Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006976 |
---|---|
Receipt number | R000008229 |
Scientific Title | Randomized phase II trial evaluating epidermal growth factor receptor- tyrosine kinase inhibitor (EGFR-TKI) plus chemotherapy in non-small cell lung cancer (NSCLC) patients with previously treated EGFR-TKI. |
Date of disclosure of the study information | 2011/12/28 |
Last modified on | 2016/10/06 14:58:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/12/28 15:58:52 | ||
2 | Update | 2014/07/07 16:18:09 | Organization Organization Division name Division name Address Address Address Address Email1 |
|
3 | Update | 2014/07/07 16:33:25 | Key inclusion criteria Key inclusion criteria Target sample size |
|
4 | Update | 2016/10/06 14:52:23 | Name of primary person or sponsor Organization |
|
5 | Update | 2016/10/06 14:53:20 | Recruitment status |
|
6 | Update | 2016/10/06 14:58:04 | Key inclusion criteria |